Harry’s World: The Science Of CBDs • High Times
The term CBD has been all over the media lately. Both Dr. Sanjay Gupta and the New York Times are talking about the helpful benefits. As a result of strains like Charlotte’s Web and other pioneering CBD-based medicine, demand has skyrocketed. But what exactly is a CBD? The name is an acronym for a cannabinoid called cannabidiol. I had the chance to interview Dr. Joshua Hartsel, P.H.D, a senior research scientist at The CannaVest Corp.
I had the pleasure of meeting Joshua at the 2013 Cannabis Cup in Amsterdam and was fascinated by his knowledge of one of the most interesting and medically valuable cannabinoids, CBD. He had entered that Cup with a CBD oil that was over 80 percent pure CBD, and went on to win the CBD category that year. It was his third time entering a Cup that year. I thought it would be interesting to ask him a few questions about the cannabinoid.
High Times: CBD is one type of cannabinoid — what makes it so amazing?
Dr. Joshua Hartsel: Until recently, CBD was not a topic of discussion in the cannabis community. People really started to talk about the benefits of CBD around 2011, and now there is a category in the High Times Cannabis Cup dedicated to high-CBD strains and concentrates, as well as extensive media exposure. This increased visibility has garnered significant interest from clinical studies for various medical indications, but also because it is a non-psychoactive substance that does not induce a “high.” Many people are familiar with Charlotte’s Web due to the documentary “Weed: Dr. Sanjay Gupta Reports,” released after Dr. Gupta’s public recanting of his position, saying the DEA “didn’t have the science to support (their) claim.” Now researchers from all over the world, including CannaVest, are focused on this interesting molecule.